|
|
Volumn 26, Issue 2, 2008, Pages 143-144
|
|
Small molecule challenges dominance of TNF-α inhibitors
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 [N [1 (2 CYANO 1 OXOETHYL) 4 METHYL 3 PIPERIDINYL] N METHYLAMINO]PYRROLO[2,3 D]PYRIMIDINE;
ABATACEPT;
ADALIMUMAB;
ANTIRHEUMATIC AGENT;
APILIMOD;
BMS 582949;
ETANERCEPT;
INFLIXIMAB;
METHOTREXATE;
MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR;
PROTEIN KINASE SYK INHIBITOR;
R 348;
R 7277;
R 788;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
RITUXIMAB;
STA 5326;
TAMATINIB FODIUM;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
UNCLASSIFIED DRUG;
ANKYLOSING SPONDYLITIS;
CLINICAL TRIAL;
CROHN DISEASE;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG SAFETY;
HUMAN;
IDIOPATHIC THROMBOCYTOPENIC PURPURA;
JUVENILE RHEUMATOID ARTHRITIS;
NEUTROPENIA;
NONHODGKIN LYMPHOMA;
NOTE;
PRIORITY JOURNAL;
PSORIATIC ARTHRITIS;
RHEUMATOID ARTHRITIS;
TUBERCULOSIS;
ULCERATIVE COLITIS;
ARTHRITIS, RHEUMATOID;
DRUG INDUSTRY;
ECONOMIC COMPETITION;
HUMANS;
OXAZINES;
PYRIDINES;
TUMOR NECROSIS FACTOR-ALPHA;
UNITED STATES;
|
|
EID: 38949110746
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0208-143 Document Type: Note |
|
Times cited : (17)
|
|
References (0)
|
